EE200000647A - Uudsed bensimidasoolid ja bensoksasoolid, nende kasutamine hingamisteede ja dermatooside raviks ette nähtud ravimite valmistamiseks ning neid sisaldav ravim - Google Patents

Uudsed bensimidasoolid ja bensoksasoolid, nende kasutamine hingamisteede ja dermatooside raviks ette nähtud ravimite valmistamiseks ning neid sisaldav ravim

Info

Publication number
EE200000647A
EE200000647A EEP200000647A EEP200000647A EE200000647A EE 200000647 A EE200000647 A EE 200000647A EE P200000647 A EEP200000647 A EE P200000647A EE P200000647 A EEP200000647 A EE P200000647A EE 200000647 A EE200000647 A EE 200000647A
Authority
EE
Estonia
Prior art keywords
benzoxazoles
dermatoses
medicaments
respiratory
manufacture
Prior art date
Application number
EEP200000647A
Other languages
English (en)
Inventor
B�r Thomas
Martin Thomas
Ulrich Wolf-R�diger
Amschler Hermann
Gutterer Beate
Flockerzi Dieter
Hatzelmann Armin
Boss Hildegard
Beume Rolf
Kilian Ulrich
Kley Hans-Peter
Original Assignee
Byk Gulden Lomberg Chemische Fabrik Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chemische Fabrik Gmbh filed Critical Byk Gulden Lomberg Chemische Fabrik Gmbh
Publication of EE200000647A publication Critical patent/EE200000647A/et
Publication of EE04641B1 publication Critical patent/EE04641B1/et

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
EEP200000647A 1998-05-05 1999-04-29 Bensimidasoolid ja bensoksasoolid, nende kasutamine hingamisteede ja dermatooside raviks ette nähtud ravimite valmistamiseks ning neid sisaldav ravim EE04641B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98108125 1998-05-05
PCT/EP1999/002900 WO1999057115A1 (de) 1998-05-05 1999-04-29 Neue benzimidazole und -oxazole

Publications (2)

Publication Number Publication Date
EE200000647A true EE200000647A (et) 2002-06-17
EE04641B1 EE04641B1 (et) 2006-06-15

Family

ID=8231881

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000647A EE04641B1 (et) 1998-05-05 1999-04-29 Bensimidasoolid ja bensoksasoolid, nende kasutamine hingamisteede ja dermatooside raviks ette nähtud ravimite valmistamiseks ning neid sisaldav ravim

Country Status (18)

Country Link
US (1) US6294564B1 (et)
EP (1) EP1075476B1 (et)
JP (1) JP2002513791A (et)
AT (1) ATE242239T1 (et)
AU (1) AU758194C (et)
CA (1) CA2331037A1 (et)
CZ (1) CZ299285B6 (et)
DE (1) DE59905847D1 (et)
DK (1) DK1075476T3 (et)
EE (1) EE04641B1 (et)
ES (1) ES2201712T3 (et)
HU (1) HUP0101678A3 (et)
IL (1) IL139317A0 (et)
PL (1) PL198759B1 (et)
PT (1) PT1075476E (et)
SI (1) SI1075476T1 (et)
WO (1) WO1999057115A1 (et)
ZA (1) ZA200006251B (et)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA83620C2 (ru) 2001-12-05 2008-08-11 Уайт Замещенные бензоксазолы и их аналоги как эстрогенные агенты

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH632628B (de) * 1976-07-26 Ciba Geigy Ag Verfahren zur herstellung von benzofuranyl-benzimidazolen und deren verwendung als optische aufheller.
DE2853765A1 (de) * 1978-12-13 1980-06-26 Bayer Ag Verfahren zur herstellung von benzimidazolylbenzofuranen
LU85544A1 (fr) * 1984-09-19 1986-04-03 Cird Derives heterocycliques aromatiques,leur procede de preparation et leur application dans les domaines therapeutique et cosmetique
US5814651A (en) 1992-12-02 1998-09-29 Pfizer Inc. Catechol diethers as selective PDEIV inhibitors
ES2192192T3 (es) 1992-12-02 2003-10-01 Pfizer Dieteres de catecol como inhibidores selectivos de pde iv.
US5998428A (en) * 1995-05-31 1999-12-07 Smithkline Beecham Corporation Compounds and methods for treating PDE IV-related diseases
US5591776A (en) 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
JP4146894B2 (ja) * 1994-07-22 2008-09-10 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング ジヒドロベンゾフラン
US5665737B1 (en) 1994-10-12 1999-02-16 Euro Celtique Sa Substituted benzoxazoles
PL319605A1 (en) * 1994-10-12 1997-08-18 Euro Celtique Sa Novel benzoxazoles
PT937075E (pt) 1996-11-11 2004-05-31 Altana Pharma Ag Novas imidazo- e oxazolo-piridinas como inibidores da fosfodiesterese

Also Published As

Publication number Publication date
CZ299285B6 (cs) 2008-06-04
PT1075476E (pt) 2003-10-31
HUP0101678A2 (hu) 2002-05-29
WO1999057115A1 (de) 1999-11-11
EE04641B1 (et) 2006-06-15
PL343848A1 (en) 2001-09-10
ATE242239T1 (de) 2003-06-15
JP2002513791A (ja) 2002-05-14
EP1075476A1 (de) 2001-02-14
PL198759B1 (pl) 2008-07-31
IL139317A0 (en) 2001-11-25
AU758194B2 (en) 2003-03-20
ES2201712T3 (es) 2004-03-16
SI1075476T1 (en) 2003-10-31
CZ20004095A3 (cs) 2001-04-11
US6294564B1 (en) 2001-09-25
AU758194C (en) 2004-04-08
HUP0101678A3 (en) 2002-06-28
EP1075476B1 (de) 2003-06-04
CA2331037A1 (en) 1999-11-11
AU3825099A (en) 1999-11-23
DE59905847D1 (de) 2003-07-10
DK1075476T3 (da) 2003-09-29
ZA200006251B (en) 2002-02-27

Similar Documents

Publication Publication Date Title
EE03523B1 (et) Fenantridiinid, neid sisaldavad ravimid ja nende kasutamine
EE04054B1 (et) Tetrasoolderivaadid, nende kasutamine ravimite valmistamiseks ja neid sisaldav ravim
EE200100350A (et) Fenüülfenantridiinid, nende kasutamine ravimite valmistamiseks ning neid sisaldav ravim
MX9707453A (es) Derivados de quinazolina.
TR200302242T2 (tr) Protein kinaz önleyicileri olarak pirolopirimidinler
DE69823344D1 (de) Substituierte benzimidazol-derivaten und ihre verwendung zur behandlung retroviraler infektionen
NO20060974L (no) Pyridazinderivater og deres anvendelse som terapeutiske midler
ES2189235T3 (es) 6-fenilfenantridinas sustituidas.
ATE452129T1 (de) N-phenyl-2-pyrimidine-amine derivatives
TW200624427A (en) Heterocyclic derivatives and their use as therapeutic agents
NO20093464L (no) Nye medikamentblandinger basert pa anti-cholinergisk effektive forbindelser og beta-mimetika
SE0101387D0 (sv) Novel compounds
DK0889886T5 (da) Hidtil ukendte, i 6-stilling substituerede phenanthridiner
YU49443B (sh) Derivati benzimidazola, postupci za njihovo pripremanje i primena tih derivata u medicinskoj terapiji, naročito za lečenje ili sprečavanje virusnih infekcija
TR200002860T2 (tr) Bir antiviral benzimidazol terkibin yeni kristal formları.
EE03829B1 (et) Bensonaftüridiinid, nende kasutamine bronhiaalravimi valmistamiseks ning neid sisaldav ravim
EE200000335A (et) Dihüdrobensofuraanid, nende kasutamine ravimite valmistamiseks ning neid sisaldavad ravimid
EE200000647A (et) Uudsed bensimidasoolid ja bensoksasoolid, nende kasutamine hingamisteede ja dermatooside raviks ette nähtud ravimite valmistamiseks ning neid sisaldav ravim
PT1290012E (pt) Derivados amida do acido 2-amino-3-hidroxi-4-tert-leucil-amino-5-fenil-pentanoico
DK1059845T3 (da) Fungicid sammensætning omfattende et benzoylphenylurinstof
NZ331374A (en) Phenanthridine compounds and pharmaceutical compositions thereof
SE9901273D0 (sv) Novel compounds

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

MM4A Lapsed by not paying the annual fees

Effective date: 20090429